The EAA publishes the Proceedings of all our conventions.
Download all EAA Proceedings Issues below
EAA Chapter France
Coming Soon
Platform Benefit Assessment* (DE)
ATMP and Orphan Diseases: Data sources beyond RCTs
EU Pharma Regulation - Impulse for Germany
Which endpoints are patient-relevant?
Interaction between HTA and authorisation
AMNOG 2.0: On the path to an efficient system
Impact of EU HTA on the AMNOG procedure
more proceedings booklets are available here
* The German Platform on Benefit Assessment is a collaboration between Springer Medicine (Springer Nature Group) with AbbVie Deutschland, DAK Gesundheit, MSD Sharp & Dohme, Novo Nordisk, Roche Pharma, vfa, Cencora.